Search Results

There are 11428 results for: content related to: Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature

  1. Therapeutic effect of lipoprostaglandin E1 on livedoid vasculitis associated with essential cryoglobulinaemia

    British Journal of Dermatology

    Volume 157, Issue 5, November 2007, Pages: 1051–1053, T. Kawakami, K. Kawasaki, M. Mizoguchi and Y. Soma

    Version of Record online : 24 AUG 2007, DOI: 10.1111/j.1365-2133.2007.08143.x

  2. Update of management of connective tissue diseases: livedoid vasculopathy

    Dermatologic Therapy

    Volume 25, Issue 2, March/April 2012, Pages: 183–194, Tania M. Gonzalez-Santiago and Mark D. P. Davis

    Version of Record online : 14 JUN 2012, DOI: 10.1111/j.1529-8019.2012.01490.x

  3. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs – a prospective study

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue 11, November 2010, Pages: 1340–1346, TB Di Giacomo, TP Hussein, DG Souza and PR Criado

    Version of Record online : 24 MAR 2010, DOI: 10.1111/j.1468-3083.2010.03646.x

  4. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells

    Acta Anaesthesiologica Scandinavica

    Volume 46, Issue 8, September 2002, Pages: 987–993, T. Koga, T. Az-Ma and O. Yuge

    Version of Record online : 21 AUG 2002, DOI: 10.1034/j.1399-6576.2002.460810.x

  5. You have free access to this content
    PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes

    Hepatology

    Volume 40, Issue 6, December 2004, Pages: 1295–1303, Emilio Siendones, Dalia Fouad, María José M. Díaz-Guerra, Manuel de la Mata, Lisardo Boscá and Jordi Muntané

    Version of Record online : 24 NOV 2004, DOI: 10.1002/hep.20448

  6. Prostaglandin E1-containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication

    Journal of Pharmacy and Pharmacology

    Volume 65, Issue 8, August 2013, Pages: 1187–1194, Tomoaki Ishihara, Yasunobu Yamashita, Naoko Takasaki, Shuhei Yamamoto, Erika Hayashi, Kayoko Tahara, Mitsuko Takenaga, Naoki Yamakawa, Tsutomu Ishihara, Tadashi Kasahara and Tohru Mizushima

    Version of Record online : 21 MAY 2013, DOI: 10.1111/jphp.12080

  7. Mononeuropathy multiplex in association with livedoid vasculitis

    Muscle & Nerve

    Volume 28, Issue 5, November 2003, Pages: 634–639, Cory Toth, Martin Trotter, Arthur Clark and Douglas Zochodne

    Version of Record online : 28 JUL 2003, DOI: 10.1002/mus.10450

  8. Determination of the binding constant between alprostadil and alpha-cyclodextrin by capillary electrophoresis: Implications for a freeze-dried formulation

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 7, July 2005, Pages: 1528–1537, Benjamin R. Schipper and Tore Ramstad

    Version of Record online : 26 MAY 2005, DOI: 10.1002/jps.20380

  9. You have free access to this content
    Livedoid vasculopathy – current aspects of diagnosis and treatment of cutaneous infarction

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 11, Issue 5, May 2013, Pages: 407–410, Nina Kerk and Tobias Goerge

    Version of Record online : 26 FEB 2013, DOI: 10.1111/ddg.12064

  10. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?

    British Journal of Dermatology

    Volume 140, Issue 1, January 1999, Pages: 131–135, ACLAND, DARVAY, WAKELIN and RUSSELL-JONES

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2133.1999.02622.x

  11. Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution

    Journal of Pharmaceutical Sciences

    Volume 96, Issue 4, April 2007, Pages: 935–943, Yukiko Komori, Tetsuya Aiba, Miki Kushima, Hiromu Kawasaki and Yuji Kurosaki

    Version of Record online : 19 JAN 2007, DOI: 10.1002/jps.20790

  12. Release of Prostaglandin E1 from N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates by Bone Cells

    Macromolecular Bioscience

    Volume 8, Issue 7, July 7, 2008, Pages: 599–605, Huaizhong Pan, Jihua Liu, Yuanyi Dong, Monika Sima, Pavla Kopečková, Maria Luisa Brandi and Jindřich Kopeček

    Version of Record online : 9 APR 2008, DOI: 10.1002/mabi.200700338

  13. You have full text access to this Open Access content
    Effects of Prostaglandin E1 on the Preparation of Platelet Concentrates in Dogs

    Journal of Veterinary Internal Medicine

    Volume 26, Issue 2, March-April 2012, Pages: 370–376, K. Segawa, T. Kondo, S. Kimura, A. Fujimoto, T. Kato, T. Ishikawa, S. Neo, M. Hisasue, T. Yamada and R. Tsuchiya

    Version of Record online : 23 JAN 2012, DOI: 10.1111/j.1939-1676.2011.00881.x

  14. Role of NF-κB activation and nitric oxide expression during PGE1 protection against d-galactosamine-induced cell death in cultured rat hepatocytes

    Liver International

    Volume 24, Issue 3, June 2004, Pages: 227–236, Dalia Fouad, Emilio Siendones, Guadalupe Costán and Jordi Muntané

    Version of Record online : 9 JUN 2004, DOI: 10.1111/j.1478-3231.2004.00913.x

  15. Prostaglandin E1 Treatment for Lumbar Spinal Canal Stenosis: Review of the Literature

    Pain Practice

    Volume 16, Issue 2, February 2016, Pages: 245–256, Hiroyuki Yoshihara

    Version of Record online : 7 JAN 2015, DOI: 10.1111/papr.12272

  16. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review

    Dermatologic Therapy

    Volume 28, Issue 5, September/October 2015, Pages: 287–290, Eun Jee Kim, So Young Yoon, Hyun Sun Park, Hyun-Sun Yoon and Soyun Cho

    Version of Record online : 6 APR 2015, DOI: 10.1111/dth.12233

  17. Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy

    Muscle & Nerve

    Volume 51, Issue 2, February 2015, Pages: 296–301, James J.P. Alix, Marios Hadjivassiliou, Rokiahmah Ali, David Slater, Andrew G. Messenger and D. Ganesh Rao

    Version of Record online : 23 DEC 2014, DOI: 10.1002/mus.24452

  18. You have free access to this content
    Prostaglandin E1 potentiation of the spontaneous phasic contraction of rat isolated portal vein by a cyclopiazonic acid-sensitive mechanism

    British Journal of Pharmacology

    Volume 120, Issue 8, April 1997, Pages: 1419–1426, Takaaki Miwa, Masayuki Endou and Fukuichiro Okumura

    Version of Record online : 11 FEB 2009, DOI: 10.1038/sj.bjp.0701051

  19. Systemic levels following PGE1 inhalation in neonatal hypoxemic respiratory failure

    Acta Paediatrica

    Volume 95, Issue 9, September 2006, Pages: 1093–1098, Beena G. Sood, Maria Glibetic, Jacob V. Aranda, Virginia Delaney-Black, Xinguang Chen and Seetha Shankaran

    Version of Record online : 29 MAR 2007, DOI: 10.1080/08035250600580511

  20. You have free access to this content
    Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay

    British Journal of Pharmacology

    Volume 138, Issue 2, January 2003, Pages: 377–385, Maria Grazia Cattaneo, Sandra Pola, Valeria Dehò, Anna Maria Sanguini and Lucia Maria Vicentini

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0705051